Skin Cancer Evaluation and Treatment

Skin Cancer Evaluation and Treatment

Skin cancer is the most common type of cancer in the United States. It can occur anywhere on the body, but it usually affects areas that have been damaged by sunlight. Your family genetics and past medical history may play major roles as well. Affecting an estimated 1 in 5 Americans in the course of a lifetime, skin cancer has the potential to strike everyone.

There are two broad categories of skin cancer.

Nonmelanoma skin cancer
Squamous cell and basal cell carcinomas are referred to collectively as nonmelanoma skin cancers. Detected early, these skin cancers usually respond well to treatment and rarely spread (metastasize) to other parts of the body.

Melanoma skin cancer
Melanoma is typically a more aggressive form of skin cancer. Left untreated, it’s likely to invade nearby tissue and metastasize. Each year, melanoma is responsible for an overwhelming majority of deaths from skin cancer.

The focus of the DermOne affiliated providers comprehensive patient-focused skin cancer program is prevention on a national level, coupled with early detection of the disease through skin cancer screenings. The tools they use to accomplish this goal are their expertise, high-impact clinical research and ability to educate patients.

If you have a skin cancer, a DermOne affiliated specialist will partner with you to choose effective skin cancer treatments and to develop strategies that will help minimize your future risk.

Skin cancers that your DermOne affiliated provider is likely to treat include the following:

  • Basal cell carcinoma
  • Cutaneous lymphoma
  • Kaposi’s sarcoma
  • Melanoma
  • Merkel cell carcinoma
  • Squamous cell carcinoma